Drawing for IMU

USPTO serial 99229180

IMU

Reviewed by CopyMark Law Group

Reg. 8157169Status 700Registered
Filing date
Status date
Registration date
Mar 3, 2026
Examiner
DINALLO, KEVIN M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
009Apparatus and instruments for detecting, measuring, analysing and testing biomarkers in samples; Apparatus and instruments for processing and analysing biological samples; Downloadable software and computer hardware for processing and analysing biological samples and biomarkers; Downloadable computer software for mapping and profiling the human immune system; Downloadable bioinformatics software for processing and analysing biological samples and biomarkers; Downloadable bioinformatics software for mapping and profiling the human immune system; Downloadable computer software platforms for processing and analysing biological samples; Downloadable computer software platforms for mapping and profiling the human immune system; Downloadable computer software platforms for connecting medical experts and patients on a personalised customisable platform; Downloadable mobile applications for processing and analysing biological samples and biomarkers; Downloadable mobile applications for mapping and profiling the human immune system; Downloadable computer application software for enabling the exchange of healthcare information and collaboration among care providers; Downloadable applications for use with clinical diagnostic tests for processing and analysing biological samples and biomarkers; Downloadable applications for use with clinical diagnostic tests for mapping and profiling the human immune system; Downloadable software applications for wellness assessment for use with clinical diagnostic tests; Downloadable electronic publications in the nature of scientific journals and downloadable reports in the fields of health and wellbeing; Medical research apparatus and instruments, namely, apparatus and instruments for detecting, measuring, analysing and testing biomarkers in samples; Parts and fittings for all the aforesaid goodsACTIVE—
042Medical research services; Medical research laboratory services; Biological research, clinical research in the field of the human immune system, and medical research; Provision of information and data relating to medical research and development in the field of the human immune system; Scientific research for medical purposes; Consultancy in relation to the aforesaid services; Software as a service services featuring software for processing and analysing biological samples and biomarkers; Software as a service services featuring software for mapping and profiling the human immune system; Platform as a service services featuring software for processing and analysing biological samples and biomarkers; Platform as a service services featuring software for mapping and profiling the human immune system; Providing an online, non-downloadable software platform for providing scientific analysis and informational reports based on the results of laboratory testing; Hosting a web portal enabling users to record, view and retrieve health outcomes and determine health plans; Information advice and consultancy in relation to all the aforesaid servicesACTIVE—
044Medical services; Human healthcare services; Provision of information relating to prevention, diagnosis, treatment and identification of medical and health disorders or imbalances; Medical and health services relating to blood testing; Medical testing services; Diagnostic medical services and advice; Medical advisory services; Telemedicine services; Providing medical information in the field of health and wellbeing; Medical services, namely, provision of information and data relating to clinical diagnostic tests; Preparation of reports in connection with medical matters; Issuing medical reports, namely, providing individual medical examination reports; Medical diagnosis services, namely, diagnosis of medical conditions and diseases in the human body; Medical evaluation services; Personalised health and medical wellbeing advice; Advisory services with respect to health, including lifestyle counselling based on individual health outcomes; Providing medical health risk assessments; Consultancy, advice and information related to the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 3, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 3, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 13, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 13, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 7, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2025DOCKASSIGNED TO EXAMINER—
Oct 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 16, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jun 16, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 11, 2025NWAPNEW APPLICATION ENTERED—
Jun 11, 2025MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance